4.7 Article

High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO):: A high-affinity 5-HT2A receptor-selective agonist radioligand

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 16, Issue 11, Pages 6116-6123

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2008.04.050

Keywords

radioligand; 5-HT2A receptor; receptor binding

Funding

  1. NIDA NIH HHS [DA02189, R01 DA002189, R56 DA002189, R01 DA002189-27] Funding Source: Medline
  2. NIMH NIH HHS [N01-MH-32005, N01MH32005] Funding Source: Medline

Ask authors/readers for more resources

The title compound ([H-3]INBMeO) was prepared by an O,O-dimethylation reaction of a t-BOC protected diphenolic precursor using no carrier added tritiated iodomethane in DMF with K2CO3. Removal of the t-BOC protecting group and purification by HPLC afforded an overall yield of 43%, with a radiochemical purity of 99% and specific activity of 164 Ci/mmol. The new radioligand was suitable for labeling human 5-HT2A receptors in two heterologous cell lines and had about 20-fold higher affinity than [H-3] ketanserin. (C) 2008 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available